Investment
Features
FeesSafety
Academy
More
Pluang+

Electrosurgery market to reach $11.59B by 2031 driven by minimally invasive surgeries and tech advances

Market News
24 Jul 2026
Researchandmarkets.Com
View Source
Bullish
pluang ai news

The global electrosurgery market is projected to grow from $8.01 billion in 2025 to $11.59 billion by 2031, at a CAGR of 6.4%. Growth is fueled by rising chronic diseases, increased surgical volumes, and demand for minimally invasive and outpatient procedures. Technological innovations in electrosurgical devices and safety features are improving patient outcomes, while ambulatory surgical centers expand their role. Challenges include procedural risks, regulatory hurdles, and surgeon shortages, but rising healthcare investments and aging populations support continued market expansion, especially in the US.

More News

Global automotive HUD market to nearly double to $4.71B by 2033 driven by ADAS and AR tech adoption

Global automotive HUD market to nearly double to $4.71B by 2033 driven by ADAS and AR tech adoption

The global automotive head-up display (HUD) market is forecasted to grow from $2.41 billion in 2026 to $4.71 billion by 2033, at a 10.1% CAGR. Growth is fueled by rising demand for driver safety, reduced distraction, and real-time vehicle info displa...

Market News
Bullish
17 minutes ago
ALPHEA raises $5M to build AI-native distributed cloud for autonomous AI agents.

ALPHEA raises $5M to build AI-native distributed cloud for autonomous AI agents.

ALPHEA secured $5 million in strategic funding to accelerate development of its AI-native distributed operating environment designed for autonomous AI agents. The platform aims to support continuous AI agent operations with efficient execution, stora...

Company Fundamentals
Bullish
22 minutes ago
Global apheresis market to reach $4.41B by 2031, driven by plasma therapies and automated tech.

Global apheresis market to reach $4.41B by 2031, driven by plasma therapies and automated tech.

The global apheresis market is projected to grow from $3.02 billion in 2026 to $4.41 billion by 2031, at a CAGR of 7.9%. Growth is fueled by rising autoimmune, neurological, and hematological diseases, increased demand for plasma-based therapies, and...

Market News
Bullish
28 minutes ago
Shell buys back 75,000 shares at average £33.43 as part of ongoing buy-back program.

Shell buys back 75,000 shares at average £33.43 as part of ongoing buy-back program.

On July 23, 2026, Shell plc purchased 75,000 of its own shares for cancellation at an average price of £33.43 per share. This transaction is part of Shell's previously announced share buy-back program initiated on May 7, 2026, managed independently b...

Company Fundamentals
Bullish
30 minutes ago
Thermo Fisher posts strong Q2 2026 with 10% revenue growth and raises full-year outlook

Thermo Fisher posts strong Q2 2026 with 10% revenue growth and raises full-year outlook

Thermo Fisher Scientific reported a 10% increase in Q2 2026 revenue to $11.99 billion and a 13% rise in adjusted EPS to $6.03, surpassing analyst expectations. The company's adjusted operating margin improved to 22.8%, driven by strong growth in its ...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App